APLS

Apellis Pharmaceuticals, Inc.

APLS · CIK 1492422 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$1.0B
20182025
Net Income$0.0B
20182025
Operating CF$0.0B
20182025
Free Cash Flow$0.0B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$1.0B$0.8B$0.4B$0.1B$0.1B$0.3B
Cost of Revenue
Gross Profit
R&D Expense$0.3B$0.3B$0.4B$0.4B$0.3B$0.3B$0.2B$0.1B
SG&A Expense$0.6B$0.5B
Operating Income$0.1B$-0.2B$-0.5B$-0.6B$-0.5B$0.1B$-0.1B$-0.0B
Net Income$0.0B$-0.2B$-0.5B$-0.7B$-0.7B$0.1B$-0.1B$-0.0B
EPS (Basic)$0.18$-1.60$-4.45$-6.15$1.03
EPS (Diluted)$0.20$-1.60$-4.45$-6.15$0.93

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$1.1B$0.9B$0.8B$0.8B$0.9B$1.0B$0.4B$0.2B
Current Assets$1.0B$0.8B$0.8B$0.7B$0.8B$0.9B$0.4B$0.2B
Cash & Equivalents$0.5B$0.4B$0.4B$0.6B$0.6B$0.6B$0.4B$0.2B
Total Liabilities$0.7B$0.7B$0.6B$0.6B$0.7B$0.8B$0.4B$0.0B
Current Liabilities$0.3B$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B
Stockholders' Equity$0.4B$0.2B$0.2B$0.2B$0.2B$0.2B$0.0B$0.2B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$0.0B$-0.1B$-0.6B$-0.5B$-0.6B$-0.2B$-0.2B$-0.1B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$0.1B$0.2B$-0.3B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.1B$0.4B$0.4B$0.4B$0.7B$0.4B$0.1B